ORPHA:228426
Syndromic multisystem autoimmune disease due to Itch deficiency
Query health: suspect — Only one of 2 strategies returned hits (recall-expansion).
Publications
0
Trials
96
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
ITCH
Definitive
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, systemic autoimmune disease characterized by , global , distinctive craniofacial dysmorphism (relative macrocephaly, dolichocephaly, frontal bossing, orbital proptosis, flattened midface with a prominent occiput, low, posteriorly rotated ears, micrognatia), hepato- and/or , and multisystemic autoimmune disease involving the lungs, liver, gut and/or thyroid gland.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013245
- OMIM:613385
- UMLS:C3150649
Additional Mondo synonyms (1)
syndromic multisystem autoimmune disease due to ITCH deficiency
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — ITCH
- LiteratureNot found
No matched Europe PMC hits under our query rules Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
96 matched on ClinicalTrials.gov (18 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ITCH).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
0
We found no papers under this exact name — work may still exist under another label.
0 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
96
interventional trials for this specific condition
96 interventional trials matched this specific condition name; 18 currently recruiting in our sample.
Data as of 27 July 2026
96 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 98.4th percentile).
low confidence · 98.4th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
96 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06081946·RECRUITING·Investigation of the Effects of Sleep Fragmentation on Itch and Pain Sensitivity
Conditions: Histamine · Cowhage · Sleep Fragmentation·Matched via recall expansion
- NCT07560618·NOT YET RECRUITING·Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Conditions: ITCH · Atopic Dermatitis·Matched via recall expansion
- NCT06340438·RECRUITING·Investigate the Relationship Between Catastrophizing and the Perception of Itch Intensity in Healthy Individuals
Conditions: Histamine · Cowhage·Matched via recall expansion
- NCT06801626·RECRUITING·Novel Strategies for Reducing Burn Scar Itch
Conditions: Burn Scar · Itch Scarring · Wound·Matched via recall expansion
- NCT06787794·RECRUITING·Reducing Itch With Hypnosis and Virtual Reality
Conditions: ITCH · Pruritus·Matched via recall expansion
- NCT06503523·RECRUITING·The Effects of Performing a Motor Imagery Task on Cortical Excitability During Acute Experimental Muscle Pain and Acute Itch
Conditions: Itch · Pain·Matched via recall expansion
- NCT06751056·RECRUITING·Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
Conditions: Pruritus·Matched via recall expansion
- NCT07580911·NOT YET RECRUITING·Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief
Conditions: Skin Pruritus · Itch · Eczema Itch · Neurodermatitis·Matched via recall expansion
- NCT06081998·RECRUITING·Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Conditions: Histamine · Cowhage · Sleep Deprivation·Matched via recall expansion
- NCT07255092·NOT YET RECRUITING·Mechanisms Underlying the Nocibo Effect of Contagious Itch. in Both Histaminergic and Nonhistaminergic Itch
Conditions: ITCH·Matched via recall expansion
- NCT07247695·RECRUITING·Mechanisms Underlying the Placebo Effect in Both Histaminergic and Non-histaminergic Itch
Conditions: ITCH·Matched via recall expansion
- NCT06328530·RECRUITING·Itch Sensation Induced by Simultaneous Application of Pruritogens (Spatial Summation)
Conditions: Histamine · Cowhage·Matched via recall expansion
- NCT07395882·NOT YET RECRUITING·A New Model to Induce Itch and Inflammation
Conditions: Itching·Matched via recall expansion
- NCT06503510·RECRUITING·Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Conditions: Itch·Matched via recall expansion
- NCT07098351·RECRUITING·Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Conditions: Adverse Event · Peritoneal Dialysis · Moderate-to-severe Pruritus · Chronic Kidney Disease-associated Itch·Matched via recall expansion
Observational and natural-history studies
13 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05678309·RECRUITING·Establishment of a Patient Library in Patients With Pruritus Sine Materia
Conditions: Pruritus · Chronic Pruritus · Itch·Matched via recall expansion
- NCT06120907·RECRUITING·Swiss Itch Registry
Conditions: Pruritus·Matched via recall expansion
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Syndromic multisystem autoimmune disease due to Itch deficiency"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Syndromic multisystem autoimmune disease due to Itch deficiency" OR "ITCH"
Recall-expansion terms: ITCH
Interventional trials matched via: recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 96 interventional · 13 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: recall-expansion
Parent literature probe: hereditary disease (MONDO:0003847) — 11220 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Zero publications but GenCC Definitive — literature likely indexed under another name; excluded from neglect count
- Trial count (96) far exceeds publication count (0) — trial matching may still be loose
Ingested 2026-07-27T10:10:59.187Z · excluded from neglect metrics
